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Abstract
Introduction: Branched chain fatty acids (BCFA) are found in the normal term human newborn’s gut, deposited as major
components of vernix caseosa ingested during late fetal life. We tested the hypothesis that premature infants’ lack of
exposure to gastrointestinal (GI) BCFA is associated with their microbiota and risk for necrotizing enterocolitis (NEC) using a
neonatal rat model.
Methods: Pups were collected one day before scheduled birth. The pups were exposed to asphyxia and cold stress to
induce NEC. Pups were assigned to one of three experimental treatments. DF (dam-fed) ; Control, hand-fed rat milk
substitute ; BCFA, hand-fed rat milk substitute with 20%w/w BCFA. Total fat was equivalent (11%wt) for both the Control
and BCFA groups. Cecal microbiota were characterized by 16S rRNA gene pyrosequencing, and intestinal injury, ileal
cytokine and mucin gene expression, interleukin-10 (IL-10) peptide immunohistochemistry, and BCFA uptake in ileum
phospholipids, serum and liver were assessed.
Results: NEC incidence was reduced by over 50% in the BCFA group compared to the Control group as assessed in ileal
tissue; microbiota differed among all groups. BCFA-fed pups harbored greater levels of BCFA-associated Bacillus subtilis and
Pseudomonas aeruginosa compared to Controls. Bacillus subtilis levels were five-fold greater in healthy pups compared to
pups with NEC. BCFA were selectively incorporated into ileal phospholipids, serum and liver tissue. IL-10 expression
increased three-fold in the BCFA group versus Controls and no other inflammatory or mucosal mRNA markers changed.
Conclusion: At constant dietary fat level, BCFA reduce NEC incidence and alter microbiota composition. BCFA are also
incorporated into pup ileum where they are associated with enhanced IL-10 and may exert other specific effects.
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Introduction
Branched chain fatty acids (BCFA) have one or more methyl
branches on the carbon chain. Most methyl branching is at the
ultimate (iso) or penultimate carbon (anteiso)( Figure 1). In
humans, BCFA are synthesized mainly by the skin, and they are
also found in colostrum and breast-milk at up to 1.5%w/w [1,2].
Thus, BCFA are a natural component of breastfed infants’ intake,
at levels similar to long chain polyunsaturated fatty acids (FA)
known to be highly bioactive. BCFA are prominent in ruminant
meat and milk, constituting 2%w/w of cow milk fat in the US
retail milk supply [3]. Finally, BCFA are a major component of the
membranes of many bacteria [4], including Lactobacilli and
Bifidobacteria [5,6], which are present in the GI tract of the early
infant [7,8].
BCFA are found in vernix caseosa at the remarkably high level
of 25–30%w/w [9]. Vernix is uniquely human, having been
reported for no other mammals [10]; there is no information on
the presence of BCFA in amniotic fluid (AF) in rats. Vernix
production by human fetal skin begins about midway through
normal gestation [11] and continues until term birth [12]. Late in
gestation, vernix becomes suspended in AF, and is swallowed by
the fetus in increasing amounts as term birth approaches [12,13].
At term, AF contains about 154 mg/L lipids overall [14] and of
these, BCFA are about 17 mg/L [15]. The fetus swallows 200–
500 ml/d of AF near term [16], providing an estimated 6 mg
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totaling 180 mg BCFA in the last month of gestation. BCFA are
present in meconium of healthy term infants [15], implying that
they persist through the length of the gut. Moreover, BCFA with
fewer than 16 carbons were detected in vernix but not in
meconium, while BCFA with at least 16 carbons were detected in
both [15]. This selective shift in BCFA distribution indicates that
the fetal alimentary canal metabolizes BCFA, suggesting that
BCFA play a metabolic role in the developing gut.
Necrotizing enterocolitis (NEC) is a major cause of morbidity in
premature infants with an estimated rate of death of 20–30%
[17,18]. Because NEC often progresses from early symptoms to
extensive necrosis within hours, prophylactic measures are
preferred [19], however none has emerged. The major risk factors
include prematurity, enteral feeding, abnormal bacterial coloni-
zation, and intestinal hypoxia-ischemia [20,21], though recent
evidence suggests the latter is not a primary mechanism [22].
Despite showing some promise, nutritional interventions including
minimal feeds [23] and probiotics [24] have been investigated
experimentally with mixed results [25]. Human milk is associated
with reduced NEC risk compared with formulas [26,27], most of
which do not contain BCFA. Other FA components of milk, in
particular docosahexaenoic acid (DHA) and arachidonic acid
(ARA), are protective against NEC [28,29]. The incidence of NEC
drops as gestational age approaches normal term [30], consistent
with the increase in BCFA gut exposure from ingested vernix. If
BCFA have a metabolically significant role in metabolism or gut
colonization, a condition of BCFA deficiency would be expected.
We speculate that development of NEC is related to the absence of
BCFA, either from vernix, breast-milk, or both.
Abnormal gut colonization leading to excess gas production and
necrosis is a hallmark of NEC [20,21]. Term infants have more
diverse GI bacteria than premature infants [31], who in turn have
more diverse microbiota than premature infants with NEC,
though no causative pathogen has emerged [32]. BCFA are
prominent membrane components of many bacterial species [4],
thus BCFA may protect against NEC by promoting the
establishment of commensal BCFA-containing bacteria.
Numerous studies document the influence of probiotics and
prebiotics on gut microbiota (e.g., [33,34,35]. Few studies have
looked at the effect of specific nutrients on microbial ecology.
Examples of these include digestion-resistant starch in adults [36],
and iron fortification in anemic children aged 6–14 y old which
supported growth of more pathogenic microbiota compared to a
non-fortified diet [37]. Numerous investigations of high fat diets of
indeterminate composition have demonstrated its effect on
bacterial ecology of the gut [38,39] but none report specifically
on the effect of FA or classes of FA with total fat held constant on
gut microbiota as in the present design, apart from a few studies of
ruminants.
Here we test the hypothesis that BCFA reduce the incidence of
NEC and systematically alter cecal microbiota of rats to favor
BCFA-containing bacteria, using an established rat pup model in
vivo. A BCFA mixture was substituted for 20%w/w of FA in
normal rat pup feed to recapitulate and simulate ingestion of
BCFA levels found in vernix. Microbiota profiling, ileal BCFA
uptake and incorporation into phospholipids (PL), serum and liver,
histological localization of interleukin-10 (IL-10), and gene
expression (mRNA) for several inflammation-related cytokines
were measured to explore the possible role of each in reducing
NEC. We find that BCFA reduce the incidence of NEC by more
then 50%, compared to the non-BCFA-fed controls. Furthermore,
formula containing BCFA alter microbiota composition, support-
ing a greater abundance of the BCFA-containing bacteria Bacillus
subtilis and Pseudomonas aeruginosa. BCFA were incorporated into
ileal membrane PL and into pup serum and liver. The anti-
inflammatory cytokine interleukin-10 (IL-10) mRNA triples in the
ileum of BCFA-fed pups compared to controls.
Materials and Methods
Animal model and diets
Ethics Statement. The protocol was approved by the University
of Arizona Animal Care and Use Committee (#A-324801-95081)
and Cornell University.
Seventy-three neonatal Sprague-Dawley rats (Charles River
Laboratory, Pontage, MI) were collected by caesarian section one
day before scheduled birth. Gender is not routinely recorded
because rats are born very immature and their gender is not
obvious, the study is complete long before sex characteristics
become dominant, and sex is not overtly related to NEC
development in humans. Pups were assigned to one of three
experimental groups: (a) dam-fed (DF, n=15), (b) hand-fed with
rat formula (Control, n=35), and (c) hand-fed with rat formula
prepared with 20%w/w of BCFA mixture (BCFA, n=23). Body
weights at the beginning of the study were 5.4060.16, 5.4460.08,
and 5.4960.16 g (means 6 SEM) for the DF, Control and BCFA
groups, respectively, and were not significantly different. Fewer rat
pups are used in the DF group because none are lost due to
treatment; fewer pups were used in the BCFA group than the
control group because of the high cost of BCFA. Pups were drawn
from eight litters in a balanced manner and randomly assigned to
treatments; no litter effects were observed on outcomes (data/
statistics not shown). The DF group is a control for general health
of the newborn pups, and differs from the other two groups with
respect to diet and maternal presence, which avoids exposure to
the stress of artificial feeding.
The BCFA mixture had six FA in purified, free FA form
(Larodan Fine Chemicals, Malmo, Sweden) in proportions similar
to their mean proportions in vernix [15]: iso-14:0 (25%), anteiso-
15:0 (20%), iso-16:0 (25%), anteiso-17:0 (8%), iso-18:0 (10%) and
iso-20:0 (12%). These were chosen because they represent the
central range of BCFA chain lengths found in vernix and are
available commercially. The Control diet composition was
described previously [40]. The BCFA diet was prepared as the
Control diet, except that (a) the fat emulsion was prepared as
described previously [41], but with BCFA added such that the
Figure 1. Structures of representative BCFA. n- (normal)
hydrocarbon chains are straight with no branching. iso-BCFA have a
bifurcated methyl branch. The systematic name for iso-15:0 is 13-methyl
tetradecanoic acid. Anteiso-BCFA have a methyl branch on the
antepenultimate carbon. anteiso-15:0 is 12-methyl tetradecanoic acid.
doi:10.1371/journal.pone.0029032.g001
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instead of almond oil to better match the FA composition of the
artificial diets and to compensate for the soy oil exchanged for
BCFA in the fat emulsion. Because they are expressed as a percent
of total FA, oleic acid (18:1n-9) and linoleic acid (18:2n-6) levels
differ between the diets due to the addition of BCFA (Table 1).
Both oleic and linoleic acids are in excess compared to
requirements and thus were reduced to accommodate BCFA
and maintain constant percent energy as fat. Each pup in the
artificial feeding groups received total diet of 850 ml/d.
NEC induction
NEC was induced in all groups as described elsewhere [42,43].
Briefly, pups were exposed to a hypoxia challenge in 100%
nitrogen gas twice daily for 1 min, followed by hypothermia-
exposure at 4uC for 10 min. After 96 h, all surviving pups were
killed by decapitation.
For microscopic evaluation, 2 cm of distal ileum were removed
and processed as described previously [42]. A histopathologist
masked to the treatments graded the histological changes using
intestinal injury scores developed previously [44]: Grade 0, normal
ileum; Grade 1, mild damage, slight submucosal and/or lamina
propria separation; Grade 2, moderate to severe separation of the
submucosa and/or lamina propria and/or edema in the
submucosal and muscular layers, partial loss of villous sloughing;
Grade 3, severe separation of the submucosa and/or lamina
propria region, villous sloughing and initial villus necrosis; Grade
4, necrosis and loss of villi structure and/or transmural necrosis
(Figure 2). Half grade increments (+0.5, 1.5, 2.5 and 3.5) were
used to more accurately assess levels of ileal damage. Rat pups
with histological scores of grade $2 were NEC positive; this value
is used because normal DF pups, which never develop NEC, are
always scored below this level.
Rat RNA preparation and reverse transcription (RT) and
real-time polymerase chain reaction (PCR)
Total RNA was isolated from ileal tissue (frozen in liquid N2)
using the RNAeasy-Plus MiniKit (Qiagen, Santa Clarita, CA) as
described in the manufacturer’s protocol. Samples were incubated
with RNAse-free DNAse (20 U/reaction) for 10 minutes at 37uC
to eliminate DNA contamination. RNA was quantified by
ultraviolet spectrophotometry, and purity was determined by the
A260/A280 nm absorbance ratio (SPECTRAmax PLUS, Molec-
ular Devices, Sunnyvale, CA). RNA purity and integrity was
determined using a NanoDrop (Thermo Fisher Scientific,
Wilmington, DE).
RT and real-time PCR assays were performed to quantify
steady state mRNA levels of the following selected cytokines (IL-
10, IL-18, interferon-c (IFN-c), tumor necrosis factor-a (TNF-a),
transforming growth factor- b (TGF-b), Mucins (Muc 2, Muc 3,
Muc 4) and trefoil factor 3 (TFF3). cDNA was synthesized from
0.5 mg of total RNA. Primers and probes were designed using
Primer Express SoftwareTM (Applied Biosystems, Foster CA).
Target probe was labeled with 6-carboxy-fluorescein (FAM)
fluorescent reporter dye. The following sequences were used:
Muc2 (GenBank BC036170): sense primer- 59-actgggaatgt-
gactgctactg-39; anti-sense primer- 59-accctggtaactgtagtaaagtc-
cat-39; and probe- 59-acaaagtgtgggtcccc-39;T N F - a (GenBank
X66539): sense primer- 59-gtgatcggtcccaacaagga-39; anti-sense
primer- 59-gggccatggaactgatgaga-39;a n dp r o b e -5 9-cccatttgg-
gaacttc-39. PreDeveloped TaqMan primers and probes were
used for the detection of Muc 3, Muc 4, TFF3, IL-10, IL-18,
IFN-c and TGF-b. Reporter dye emission was detected by an
automated sequence detector combined with ABI Prism 7700
Sequence Detection SystemH software (Applied Biosystems).
Real time PCR quantification was then performed using
TaqManH 18S controls. mRNA levels are expressed as multiples
of the values determined for the DF group and are presented as
means 6 SEM.
DNA extraction and amplification
Thirty three cecal samples were used for bacterial analysis from
the rat pups (DF, n=10; Control, n=10; BCFA, n=13). The
samples were processed as described previously [38]. Genomic
DNA was isolated using the PowerSoilH DNA isolation kit (MoBio
Laboratories Ltd, Carlsbad, CA). 16S rRNA genes were amplified
by PCR from each of the 33 samples using a composite forward
primer and a reverse primer containing a unique 12-base barcode
[45] which was used to tag PCR products from respective samples
[46]. We used the forward primer 59- GCCTTGCCA GCC-
CGCTCAGTCAGAGTTTGATCCTGGCTCAG -399 : the itali-
cized sequence is 454 Life Sciences primer B, and the bold
sequence is the broadly conserved bacterial primer 27F. The
reverse primer was 59-GCCTCCCTCGCGCCATCAGNNNNNNNN-
NNNNCATGCTGCCTCCCG TAGGAGT-39: the italicized
sequence is 454 Life Sciences primer A, and the bold sequence
is the broad-range bacterial primer 338R. NNNNNNNNNNNN
designates the unique 12-base barcode used to tag each PCR
product, with ‘‘CA’’ inserted as a linker between the barcode and
rRNA gene primer. PCR reactions were carried out in triplicates
and consisted of 2.5 U Easy-A high-fidelity enzyme and 16buffer
(Stratagene, La Jolla, CA), 200 mM of each primer, and the
reaction conditions consisted of initial denaturation step at 95uC
for 2 min followed by 30 cycles of denaturation at 95uC for 40 s,
annealing at 57uC for 30 s, and extension step at 72uC for 1 min,
Table 1. Fatty acid (FA) composition of Control and BCFA
diets determined by gas-chromatography (GC) analysis.
FA Control BCFA
10:0 1.2 1.0
12:0 1.5 1.4
iso-14:0 0.1 4.9
14:0 4.8 4.8
14:1n-5 0.5 0.5
anteiso-15:0 0.2 3.9
15:0 0.5 0.5
iso-16:0 0.1 5.1
16:0 19.5 16.8
16:1 1.0 0.8
anteiso-17:0 0.2 1.6
17:0 0.3 0.3
iso-18:0 n.d. 1.9
18:0 8.5 8.0
18:1n-9 30.7 21.5
18:2n-6 27.1 20.8
iso-20:0 n.d. 2.5
18:3n-3 3.3 3.1
20:0 0.5 0.5
22:0 0.2 0.2
n.d., not detected.
doi:10.1371/journal.pone.0029032.t001
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were pooled. A negative control sample was treated as described
above, except that no template DNA was added to the PCR
reaction. PCR amplicons were purified using a magnetic bead
system (Mag-BindH EZPure, Omega Bio-Tek, Norcross, GA) and
the amplicons were quantified using the QuantiT PicoGreen
dsDNA Assay Kit (Invitrogen, Carlsbad, CA). Aliquots of
amplicons (at equal masses) were combined into a single tube
with a final concentration of 7.5 ng/ul. The samples were
sequenced using the 454-sequencing platform (using Titanium
chemistry) at Engencore, University of South Carolina.
Sequences were analyzed with the software package ‘‘Quanti-
tative Insights into Microbial Ecology’’ (QIIME). Sequences were
removed if lengths were ,200 or .1000 nt; contained ambiguous
bases, primer mismatches, homopolymer runs in excess of six
bases, or uncorrectable barcodes.
16S rRNA gene sequence analysis
The quality-checked sequences were denoised [47] and
processed using QIIME [48]. Similar sequences were binned into
operational taxonomic units (OTUs) using UCLUST [49], with a
minimum pairwise identity of 97% and taxonomy was assigned to
representative sequences using the Greengenes database [50].
Fatty acid analysis
Serum, ileal and liver samples were collected from the Control
(n=4) and BCFA (n=3) groups for FA analysis. Dietary lipids and
ileal, liver and serum samples were extracted using a modified
Bligh and Dyer method [51]. Ileal lipids were loaded on thin layer
chromatography (TLC) plates (Silica gel G, 20620, Analtech, Inc.,
Newark, DE). Plates were developed halfway in hexane:diethyl-
ether:acetic acid (40:60:1, v:v:v), dried, and redeveloped with
heptane:diethyl-ether:formic acid (80:20:1.8, v:v:v). Lipid bands
were visualized in iodine vapor and the PL fraction was collected.
Fatty acid methyl esters (FAME) for dietary lipids, ileal PL, liver
and serum were prepared using 14% BF3/MeOH (Sigma
Chemical, St. Louis, MO).
FAME analyses were performed as described previously [15],
except that a BPX-70 column (25 m60.22 mm60.25 mm) (SGE,
Austin, Tx) was used for gas chromatography (GC) analysis. FA
levels are expressed as %, weight-for-weight (%w/w).
Immunohistochemistry (IHC)
A 2-cm section of distal ileum was collected from each rat pup,
and processed as described previously [42]. After deparaffinization
and rehydration, sections were blocked in 5% bovine serum
albumin (BSA) to prevent non-specific staining and incubated with
Figure 2. Representative histology of neonatal rat pup terminal ileum. Histological changes were graded as described in the methods
section. Briefly: 0, normal ileum; 1–3, mild, moderate, or severe damage reflecting degrees of separation of submucosa and/or lamina propria,
regional villous sloughing and initial necrosis; 4, necrosis. Pups were considered to have NEC if their histological score was $2. Magnification: 2006.
doi:10.1371/journal.pone.0029032.g002
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Biotechnology, Santa Cruz, CA), followed by incubation with
Alexa Fluor 594 conjugated anti-goat secondary antibody
(Molecular Probes, Eugene, OR) for 1 h and coverslipped with
Prolong gold anti-fade reagent with 4,6-diamidino-2-phenylindole
(DAPI). An Olympus IX-70 inverted fluorescent microscope
equipped with a 406oil immersion objective was used to evaluate
IL-10 staining. For quantification of fluorescence signal, digital
images were saved in Adobe Photoshop CS5 and analyzed using
ImageJ software (NIH, USA). Statistical comparison of densities in
three samples from each experimental group was performed using
one-way analysis of variance (ANOVA).
Statistical analysis
A power calculation was based on mean NEC scores and
standard deviations from previous work in which the mean and
standard deviation scores for the control and tested agent were
1.6160.70, and 1.1660.50 respectively [42]. At least 21 animals
were needed in each artificial feeding group for a significance level
of 0.05 and 80% power using PROC POWER in SAS 9.2 (Cary,
NC). We allocated 23 and 35 pups in the BCFA and control
group, respectively. The Fisher Exact Test (R software [52]) was
used to test the null hypothesis that the incidence of NEC is the
same in the BCFA and control groups at p,0.05.
To test for differences in pup weights at the beginning and at
the end of the study, and to test for differences in BCFA levels in
ileum PL, serum and liver, ANOVA followed by Tukey’s least
significant difference (JMP 8, SAS Institute, Cary, NC) was used.
ANOVA followed by Fisher’s protected least significant differ-
ence (StatView for Macintosh, Abacus Concepts, Inc., Berkeley,
CA) was used to analyze differences in gene expression and in IL-
10 peptide IHC.
Differences in relative abundance of OTUs among the
experimental groups were analyzed as described below using a
mediation model [53] in two stages (R software [52]). In the first
stage the response is the histology score, measured as a continuous
variable which takes values between 0 and 4. The independent
variables are the groups (BCFA, DF, or Control, with 11, 8, and 9
pups, respectively), and the bacteria count (BC). The following
linear model was fitted:
Score~InterceptzGroupzBCj
for each of the 29 OTUs (indexed by j). For each model, we
obtained the p-value based on the F-statistic (testing whether none
of the explanatory variables is significant, versus the alternative
that at least one of the two explanatory variables is significant).
The Bonferroni method was used to adjust the p-values for
multiple testing of 29 OTUs. Controlling the Type-I error at a 5%
level, a total of four models were significant, corresponding to
Pseudomonas aeruginosa, Clostridium, Bacillus subtilis, and Lactobacillus.
In the second stage we assessed whether for these four bacteria,
the BC variable was also affected by the treatment. The
Generalized Linear Models (GLM) framework [54] was used to
fit a Poisson model with a log link function:
log E BC ðÞ ðÞ ~InterceptzTreatment
That is, the expected logarithm of bacteria count is a linear
function of the treatment group.
As often observed when fitting a Poisson model to count data,
we observed over-dispersion (the observed variance was larger
than the mean). We adjusted the GLM fit accordingly.
Finally, to perform the three pairwise comparisons (between
groups) and account for multiple testing, Tukey’s honest
significance test was used. After Tukey analysis, Bacillus subtilis
and Pseudomonas aeruginosa were significantly different among the
groups. The same statistical procedure was followed for the nine
most abundant OTUs. The relative abundance of the various
OTUs was positively skewed distribution and these data were
natural log transformed for comparison. A significance level of
p,0.05 was used.
Results
Clinical evaluation
Survival rate was similar among all groups with 87% (13/15),
89% (31/35), and 91% (21/23) in the DF, Control and BCFA
groups, respectively. Body weights at the end of study were
8.0660.24, 5.9760.05, and 5.6960.10 g (means 6 SEM) for the
DF, Control and BCFA groups, respectively. There were no
significant differences in body weight between the Control and
BCFA groups. The high relative weight of DF pups compared to
the artificial feeding groups (p,0.05) was similar to previous
studies [44,52].
NEC incidence
Histological NEC scores (Figure 3A) and the incidence of NEC
(Figure 3B) in the experimental groups are plotted individually and
summarized according to whether they had a score of 2 or greater
indicative of NEC. Pups in the DF group do not normally develop
NEC and no pup in the present study exhibited an abnormal
intestinal architecture. In the Control group, 17 of 31 pups (55%)
had a score of 2 or greater, indicating NEC injury. In contrast, the
BCFA group had histological scores of 2 or greater in 5 of 21 pups
(24%). The null hypothesis of no difference in NEC incidence
between artificial feeding group was rejected (p=0.044); BCFA
reduced the incidence of NEC by 56% (55% vs 24%).
Bacterial diversity
Nine OTUs at the family level predominated in the bacterial
microbiota of all pups. Bacillaceae and Pseudomonadaceae families
were significantly more abundant in the BCFA-fed pups compared
to the Control group (Figure 4).
At the species level, the relative abundance of Bacillus subtilis was
significantly higher in the BCFA group compared to the Control
group, but not significantly different than the DF group (Figure 5).
The relative abundance of Pseudomonas aeruginosa was significantly
higher (p,0.05) in the BCFA-fed group compared to the Control
and DF group. Moreover, the relative abundance of B. subtilis was
significantly higher (p,0.05) in the healthy animals compared to
sick animals (Figure 6). The difference was significant even when
the DF group, all of which were healthy, was excluded from the
analysis (not shown).
BCFA in rat ileum PL, serum and liver
BCFA concentrations in the diets and in ileum PL fraction,
serum and liver (%w/w; mean 6 SD) of 3 pups without NEC from
the BCFA group and 4 pups from the Control group are presented
in Figure 7. Compared to their proportions in the diet
(Figure 7A), BCFA were taken up by the ileum of the BCFA-
fed pups (Figure 7B) and were incorporated in the ileum PL in a
structure-selective manner: iso-14:0 and anteiso-15:0 were selected
against and iso-18:0 was enriched in PL. This incorporation
pattern was similar also in the serum and in the liver of the BCFA-
fed animals (Figures 7C and 7D). Moreover, iso-14:0 was
selected against in ileum compared to serum or liver. By contrast,
Branched Chain FA, Microbiota and NEC
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from the Control group were at trace levels and may be due to
endogenous synthesis from catabolized branched chain amino
acids. Concentrations of non-branched FA in the ileum PL
fraction as well as in the serum and in the liver were similar
between the artificial feeding groups (data not shown), including
oleic acid and linoleic acid, which differed in the diets. These data
point to effects specific to BCFA and not to other FA in the diets.
Interleukin (IL-10) mRNA and peptide localization
Ileal IL-10, mucins, and trefoil factor 3 mRNA levels probed by
RT-PCR in ileum are presented in Table 2. IL-10 levels in the
BCFA group were more than three-fold the values in the DF and
Control groups. No other differences in mRNA were found
between the artificially fed groups.
IHC was used to localize IL-10 peptide in pup ileum to further
investigate gene upregulation in the BCFA group compared with
the Control group, because gene expression changes are not
strongly correlated with protein abundances. Typical IHC slides of
ileal IL-10 peptide show that IL-10 is enhanced in the BCFA
group (Figure 8). DF and BCFA pups displayed moderate IL-10
peptide in the villi cell cytoplasm. IL-10 signal intensity was
significantly higher (fourfold, p,0.001) in BCFA and DF pup
sections compared with the Control ileum.
Discussion
BCFA are constituents of the GI tract of normal, healthy, term
newborns [15]. In the present study, oral administration of BCFA
was used to simulate the ingestion of BCFA-rich vernix by the
human fetus. BCFA reduced the incidence of NEC among
artificially-fed rat pups. There were no cases of NEC in pups from
the DF group, presumably because this group enjoyed other
nutritional benefits of dam-milk and the nurturing benefits of
maternal care that may have enhanced the DF pups’ resistance.
Figure 3. Histological scores and NEC incidence. (A) Histological
scores and (B) incidence of NEC in rat pups in all experimental groups:
DF, n=13; Control, n=31. BCFA n=21 Pups were considered to have
NEC if their histological score was $2; The incidence of NEC was
significantly lower in the BCFA group compared to the Control group*
p,0.05 Control vs. BCFA.
doi:10.1371/journal.pone.0029032.g003
Figure 4. Distribution of the most abundant OTUs at the family level. The relative abundance (%) of the OTUs at the family level in the
various experimental groups. DF (n=8); Control (n=9); BCFA (n=11). *p,0.05 for group differences.
doi:10.1371/journal.pone.0029032.g004
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C26, while that of meconium is from C16 to C26. Short BCFA
entering the GI tract as AF-suspended vernix do not appear in
meconium, indicating that BCFA are metabolized by the fetal gut.
Here, dietary BCFA are incorporated in a structure-selective
manner into the PL fraction of the ileum. Selection against short
BCFA (,16 carbons) for incorporation into the PL fraction is
consistent with our previous observation showing a systematic shift
of BCFA distribution between vernix and meconium [15]. These
results demonstrate that BCFA are not inert components of the GI
tract, but are selectively incorporated into membrane lipids
mediated by enterocytes, and are further transferred into
circulation and to the liver.
The reduction in NEC incidence reported here is similar to
most prophylactic treatments targeting NEC in experimental
studies [53,54,55]. Our results are consistent with the hypothesis
that altered FA membrane composition may change enterocyte
resistance to initiating events associated with NEC. Moreover, the
entry and possible accumulation or turnover of BCFA could
contribute to signaling the GI tract that normal parturition is
approaching and that the dramatic shift between AF and full
reliance on breast-milk is imminent. An analogy can be drawn to
the rise in blood cortisol that signals the lungs to increase
Figure 5. The relative abundance of Bacillus subtilis and Pseudomonas aeruginosa. The relative abundance (%; mean 6 SEM) of Bacillus
subtilis and Pseudomonas aeruginosa differed significantly among the experimental groups. DF (n=8); Control (n=9); BCFA (n=11). Means not
marked by the same letter are significantly different (p,0.05).
doi:10.1371/journal.pone.0029032.g005
Figure 6. The relative abundance of Bacillus subtilis and health
status. The relative abundance (%, mean 6 SEM) of Bacillus subtilis in
healthy animals and in animals with NEC. The relative abundance of
Bacillus subtilis was higher in healthy animals regardless of diet group
compared to animals with NEC. *p,0.05.
doi:10.1371/journal.pone.0029032.g006
Figure 7. BCFA concentrations in the Control and BCFA groups.
BCFA concentrations (%w/w) in (A) diets, and in a subset of Control and
BCFA-fed pup (B) ileum PL, (C) serum, and (D) liver. Data are expressed
as means 6 SD (n#4). Compared to their proportions in the diet, BCFA
were incorporated in a selective manner in the ileum PL, serum and
liver of the BCFA-fed pups. Iso-14:0, iso-18:0, and iso-20:0 are
significantly altered as a fraction of BCFA in ileum, serum, and liver
(p,0.05).
doi:10.1371/journal.pone.0029032.g007
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because lung surfactant PL appear to have a role in vernix
particle entry into the AF [12], and thus levels of the two may be
correlated for some infants.
The cecal microbiota results show that BCFA in formula, with
total fat held constant, alters the relative abundance of bacterial
families in the cecal microbiota. In particular, the relative
abundance of each of two prominent BCFA-containing bacteria,
B. subtilis and P. aeruginosa, was higher in the BCFA group
compared to the Control group. BCFA levels in B. subtilis are 95%
of the total FA [4], while those in P. aeruginosa can range from 0.3–
16% of the total FA depending on growth conditions [56,57].
Since the abundance of other types of bacteria was similar between
treatments, it is likely that other factors beyond a supply of BCFA
played a role in specifically enhancing some organisms over others
and that pup-to-pup variability may also have masked more subtle
changes in BCFA-reliant organisms.
B. subtilis is considered a commensal bacterium and is used as a
probiotic [58]. Elevated levels of B. subtilis have been associated
with improved macroscopic lesion scores, reduced levels of pro-
inflammatory cytokines, and increased anti-inflammatory cytokine
levels in colitis-induced animals compared to untreated colitis-
induced animals [59]. B. subtilis levels have also been associated
with improved performance (weight gain, intake, weaning age) and
immune function (higher serum IgG) of preweaning calves, but did
not affect IL-10 levels [60]. Though the relative abundance of
B.subtilis was significantly higher in the BCFA group compared to
the Control group, no correlation was found between the relative
abundance of B. subtilis and cytokine mRNA levels, including IL-
10 mRNA levels (data not shown). Nonetheless, the relative
abundance of B. subtilis was higher in healthy animals regardless of
treatment, suggesting it may play an elementary role in reducing
the incidence of NEC. Further studies are necessary to establish
whether B. subtilis may be a component of an effective prophylactic
probiotic against NEC.
P. aeruginosa was significantly more abundant in the BCFA group
compared to the Control group despite a lower NEC incidence in
the BCFA group. In addition, P. aeruginosa levels were similar in the
DF group and the Control group, despite the lack of NEC in the
DF group. Reports of P. aeruginosa association with NEC are mixed
[61,62]. Recent data show that BCFA, specifically iso-14:0, anteiso-
15:0 iso-16:0, and anteiso-17:0, repress motility in P. aeruginosa
without significantly inhibiting its growth in liquid cultures [63]. A
plausible explanation for the higher abundance of P. aeruginosa in
the BCFA group, despite lower NEC incidence, is that BCFA in
our study supported P. aeruginosa growth while repressing its
motility and its consequent pathogenicity. Finally, P. aeruginosa may
not be associated with NEC, regardless of treatment, under the
conditions of our study.
Changes in IL-10 mRNA and protein also suggest possible
mechanisms of BCFA protection against NEC. Ileal IL-10
expression was greater in the BCFA group relative to the Control
group, as were IL-10 peptide levels in the IHC samples. IL-10
knockout mice spontaneously develop chronic enterocolitis
throughout the intestinal tract [64]; early IL-10 administration
prevented the development of enterocolitis in these mice,
suggesting that IL-10 counterbalances effectors present in
intestinal lesions [65]. Similarly, the protective effect of epidermal
growth factor (EGF) against NEC was associated with a tripling of
ileal mRNA IL-10 [66]; reduced NEC incidence in rat-milk-fed
versus formula-fed pups was associated with a twofold increase of
ileal IL-10 mRNA [52]. Others showed that subcutaneous
administration of recombinant human IL-10 to the intestine of
NEC-induced neonate rats reduced the severity of microscopic
ileal lesions compared with untreated rats [67]. Thus, elevated
Table 2. Cytokine, Muc, and TFF3 mRNA levels in ileum of DF,
Control and BCFA-fed neonatal rats
1,2.
DF Control BCFA
IL-10 1.060.1 1.060.1 3.261.5*
TGF-b 1.060.1 0.760.1
{ 0.760.1
{
IL-18 1.060.1 1.360.1 1.760.1
{
TNF-a 1.060.1 2.460.8 2.760.7
{
IFN-c 1.060.3 0.460.1
{ 0.760.4
Muc 2 1.060.1 0.560.1
{ 0.460.1
{
Muc 3 1.060.1 1.660.3 1.260.2
Muc 4 1.060.1 0.360.8
{ 0.160.1
{
TFF3 1.060.1 1.360.2 1.660.2
1Mean steady-state mRNA levels of the Control-fed and BCFA-fed groups are
expressed as fold changes relative to corresponding values for the DF group.
2Data are means 6 SEM; n=10–23 pups per treatment.
*p,0.05 vs. Control and vs. DF.
{p,0.05 vs. DF.
doi:10.1371/journal.pone.0029032.t002
Figure 8. IHC images of IL-10. IHC images of IL-10 in healthy (score#1.5) ileal sections from DF, Control, and BCFA pups. IL-10 is green, nuclear
material is blue. Magnification: 4006. Compared to the Control group, IL-10 is increased in the BCFA group.
doi:10.1371/journal.pone.0029032.g008
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group, possibly by opposing proinflammatory effects. The higher
mRNA levels of IL-10 in the BCFA group compared to the DF
group can be explained by the lower levels of proinflammatory
cytokines in the DF group, where no additional production of IL-
10 was required to counteract them [52].
Proinflammatory cytokines are important factors in NEC
pathogenesis [66,68,69]. Caplan et al [70] observed high plasma
levels of TNF-a in infants with NEC, but no correlation between
TNF-a levels and severity of disease. Here, ileal TNF-a gene
expression was greater in the artificial feeding groups compared
with DF pups. BCFA treatment did not specifically affect TNF-a
mRNA levels. IFN-c mRNA was significantly lower in the Control
group compared to DF but the BCFA group was not different.
The relationship of IFN-c in NEC is ambiguous. Elevated
intestinal IFN-c levels have been reported in NEC patients [71],
however no significant differences in IFN-c were found between
formula-fed-hypoxic NEC rats and non-hypoxic formula-fed
groups with mild intestinal damage in a study similar to ours
[72] and in separate studies ileal IFN-c mRNA was not related to
NEC development in neonatal rat pups [68].
Dietary iso- and anteiso-BCFA have not previously been studied
in the context of human diet. This is the first study to investigate,
and show, a protective effect of dietary BCFA on NEC. In
humans, BCFA are ingested and absorbed in substantial amounts
in utero as AF suspended vernix particles. Since vernix is uniquely
human, interspecies comparison must be viewed with caution.
Nevertheless, preclinical in vivo models are crucial for establishing
safety and efficacy, and neonatal rats are an accepted model for
NEC in human infants. In addition, we used six pure BCFA with
chain length distribution from 14 to 20 carbons and in iso- and
anteiso- branching types; vernix contains BCFA with a larger chain
length range, 11 to 26 carbons, and with additional branching
types [15]. Future research will delve more deeply into the
influence of a larger variety of BCFA on intestinal microbial
communities in NEC while seeking to replicate the beneficial effect
of BCFA on NEC.
In conclusion, BCFA reduced the incidence of NEC by 56% in
a neonatal rat pup model. The bacterial analysis showed that
formula containing 20% of fat as BCFA, similar to the
concentration in vernix, alters microbiota composition, in turn
suggesting that BCFA are used by cecal bacteria. The greater
abundance of B. subtilis and P. aeruginosa suggests that these or other
BCFA-using organisms may participate in the BCFA moderating
effect on NEC incidence. In addition, an increase in ileal IL-10 in
the BCFA-fed group and a selective incorporation of these FA into
membrane lipids may be also associated with a protective effect of
BCFA against NEC.
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